Korro Bio, Inc. 8-K

What Happened
Korro Bio, Inc. (KRRO) filed a Form 8-K on January 15, 2026 (Item 8.01) to disclose that it updated its corporate presentation for use in meetings with investors, analysts and others. A copy of selected, updated slides is included with the filing as Exhibit 99.1.

Key Details

• Filing date: January 15, 2026 (Form 8-K, Item 8.01: Other Events).
• Document included: Selected slides from the updated corporate presentation, filed as Exhibit 99.1.
• Purpose: Presentation intended for investor, analyst and other external meetings (no new financial statements or executive changes were reported).

Why It Matters
This 8-K makes Korro Bio’s refreshed investor materials publicly available, so shareholders and analysts can review the company’s latest messaging, strategy and any slide-deck updates. The filing does not report earnings, revenue figures, executive appointments, or material financial results—only the updated presentation slides were furnished. Investors who follow company guidance, pipeline updates, or strategic priorities should review Exhibit 99.1 to see the current information Korro Bio is presenting to the market.